Anxiety and depression-Important psychological comorbidities of COPD

被引：238

作者：

Pumar, Marsus I. ^{[1
,2
,3
]}

Gray, Curt R. ^{[3
,4
]}

Walsh, James R. ^{[3
,5
,6
]}

Yang, Ian A. ^{[1
,2
,3
]}

Rolls, Tricia A. ^{[6
,7
]}

Ward, Donna L. ^{[6
,8
]}

机构：

[1] Prince Charles Hosp, Metro North Hosp & Hlth Serv, Dept Thorac Med, Brisbane, Qld 4032, Australia

[2] Prince Charles Hosp, Metro North Hosp & Hlth Serv, Dept Infect Dis, Brisbane, Qld 4032, Australia

[3] Univ Queensland, Sch Med, Brisbane, Qld, Australia

[4] Prince Charles Hosp, Dept Mental Hlth, Brisbane, Qld 4032, Australia

[5] Prince Charles Hosp, Metro North Hosp, Physiotherapy Dept, Brisbane, Qld 4032, Australia

[6] Hlth Serv, Brisbane, Qld, Australia

[7] Prince Charles Hosp, Metro North Hosp, Dept Psychol, Brisbane, Qld 4032, Australia

[8] Metro North Hosp, Caboolture Hosp, Allied Hlth Dept, Caboolture, QLD, Australia

来源：

JOURNAL OF THORACIC DISEASE | 2014年 / 6卷 / 11期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

Chronic obstructive pulmonary disease (COPD); anxiety; depression; comorbidities; diagnosis; therapy; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; FACE-TO-FACE; TELEPHONE-ADMINISTERED PSYCHOTHERAPY; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; CASE-FINDING INSTRUMENTS; HOSPITAL ANXIETY; PANIC DISORDER; SYSTEMIC INFLAMMATION;

D O I：

10.3978/j.issn.2072-1439.2014.09.28

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

100201 [内科学];

摘要：

Anxiety and depression are common and important comorbidities in patients with chronic obstructive pulmonary disease (COPD). The pathophysiology of these psychological comorbidities in COPD is complex and possibly explained by common risk factors, response to symptomatology and biochemical alterations. The presence of anxiety and/or depression in COPD patients is associated with increased mortality, exacerbation rates, length of hospital stay, and decreased quality of life and functional status. There is currently no consensus on the most appropriate approach to screening for anxiety and depression in COPD. Treatment options include psychological [relaxation, cognitive behavioural therapy (CBT), self-management] and pharmacological interventions. Although there is some evidence to support these treatments in COPD, the data are limited and mainly comprised by small studies. Pulmonary rehabilitation improves anxiety and depression, and conversely these conditions impact rehabilitation completion rates. Additional high quality studies are urgently required to optimise screening and effective treatment of anxiety and depression in patients with COPD, to enhance complex chronic disease management for these patients.

引用

页码：1615 / 1631

页数：17

共 150 条

[1]

Abrams TE, 2011, PSYCHOSOMATICS, V52, P441, DOI 10.1016/j.psym.2011.03.005

[2]

Abramson M, 2014, BEHALF LUNG FDN AUST

[3]

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD [J].